HOME >> MEDICINE >> NEWS
AMITIZA(TM) (lubiprostone) shown effective and well-tolerated in people older than age 65

AMITIZA(TM) (lubiprostone), the first selective chloride channel activator for the treatment of chronic idiopathic constipation, was effective and well-tolerated in treating the symptoms of chronic idiopathic constipation in the elderly adult population according to findings presented during a poster session today at Digestive Disease Week 2006.

"AMITIZA is unique among prescription treatments for chronic idiopathic constipation, given its novel mechanism of action, which has been shown to provide targeted and predictable relief to people living with this condition," said John Johanson, M.D., clinical associate professor, University of Illinois College of Medicine. "These results further support that AMITIZA may fill an important unmet need for many patients, especially those over age 65, for whom there are limited prescription treatment options currently available to treat chronic idiopathic constipation."

Predictable relief is defined as the ability of study participants to have three spontaneous bowel movements or more per week.

Constipation is one of the most common digestive complaints, affecting more than 30 million Americans, and is especially prevalent in adults over the age of 65. It is the cause of 2.5 million visits to physicians and 92,000 hospitalizations annually. AMITIZA is the only prescription medication for chronic idiopathic constipation that can be used in people age 65+ for longer than two weeks. Approximately one of four patients over 65 suffers from chronic constipation, a condition that increases with age-related bowel changes.

AMITIZA, approved by the U.S. Food and Drug Administration (FDA) in January 2006, is an oral treatment that works by increasing fluid secretion in the small intestine by activating ClC-2 chloride channels, and thereby increasing the passage of the stool and improving symptoms associated with chronic idiopathic constipation. AMITIZA was developed by Sucampo Pharmaceuticals, Inc., an
'"/>

Contact: Jocelyn M. Gerst
847-383-3696
Ketchum
22-May-2006


Page: 1 2

Related medicine news :

1. New study demonstrates that AMITIZA (lubiprostone) may help improve symptoms
2. AMITIZA (lubiprostone) launches in the United States
3. Pro-vitamin E shown to be active against breast cancer cells
4. Ultra low-dose estrogen shown safe for post-menopausal women
5. ROZEREM (ramelteon) shown to be effective in a first-night-effect model of transient
6. Radiation therapy shown to increase survival in certain lung cancer patients
7. Drug shown to provide much needed alternative therapy for chronic shoulder pain
8. Nexium shown to reduce gastric ulcers in at-risk patients using long-term NSAIDS
9. State board-disciplined physicians more likely to have shown unprofessional behavior in med school
10. Technology for successful aging shown at White House conference
11. Stress echo tests shown to predict cardiac death, illness in higher-risk women

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/15/2018)... ... September 14, 2018 , ... Today, ... will showcase the innovative work being done within rare diseases research, diagnostics, and ... those living with rare diseases. , Clay Matthews, Super Bowl-winning ...
(Date:9/13/2018)... (PRWEB) , ... September 13, 2018 , ... Pulsara is ... Health IT + Revenue Cycle Conference on September 19-22 in Chicago. Dr. Woodson, ... panels as well as a talk titled, “Your Clinical Communication & Collaboration (CC&C) is ...
(Date:9/12/2018)... ... 2018 , ... Donaldson Plastic Surgery has been included on the Inc. 5000 ... 50 list of central Ohio's fastest growing businesses. The plastic surgery practice was ranked ... It is the only medical practice and plastic surgery office to make the regional ...
(Date:9/7/2018)... , ... September 07, 2018 , ... ... College District , the only OSHA authorized OTI Education Center headquartered in Northern ... assist employees who feel they have experienced retaliation in response to engaging in ...
(Date:9/2/2018)... ... September 02, 2018 , ... Eaton ... social change. The hotel itself, which opened this week, inspires creativity and innovation ... or more. , Eaton Hotel DC currently features 209 hotel rooms, a wellness ...
Breaking Medicine News(10 mins):
(Date:9/13/2018)... ... September 13, 2018 , ... NCPDP ... to test and ensure correct implementation of the NCPDP SCRIPT Standard Version 2017071 ... important functionality and transactions identified by the industry as vital enhancements in improving ...
(Date:9/12/2018)... ... September 12, 2018 , ... ... Cycle Conference in Chicago, IL, from September 19-22. The IT + Revenue Cycle ... patient engagement and empowerment with the use of Precision Virtual Reality™ medical visualization ...
(Date:9/7/2018)... ... September 06, 2018 , ... This year, the California Society of Plastic Surgeons ... of: IDEAL IMPLANT® - Seven-Year Clinical Trial Results at the 68th CSPS Annual Meeting. ... upcoming ASPS (American Society of Plastic Surgeons) meeting in Chicago this fall. , “I ...
Breaking Medicine Technology:
Cached News: